Nicotinell Tropical Fruit (Nicotine Polacrilex)

Nicotine Polacrilex, the active ingredient in Nicotinell Tropical Fruit, is a nicotine replacement therapy presented as a buccal delivery system for buccal use. It delivers controlled nicotine to the oral mucosa, helping adult smokers reduce cravings, alleviate withdrawal symptoms, and increase the likelihood of successful tobacco cessation.

GNH USA supplies Nicotinell Tropical Fruit as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide, providing consistent quality and regulatory‑aligned products for global nicotine‑cessation programs, through reliable supply chains and compliance with EU standards.

Nicotinell Tropical Fruit, containing nicotine polacrilex, is used in nicotine replacement therapy to address tobacco dependence and related withdrawal. - Smoking cessation: assists adult smokers in quitting by reducing cravings and withdrawal symptoms. - Relapse prevention: supports individuals who have quit smoking to maintain abstinence. - Nicotine withdrawal relief: alleviates symptoms such as irritability, anxiety, and difficulty concentrating during the quitting process.

Common and serious adverse reactions may occur with buccal nicotine delivery.

Common Side Effects: - Mouth irritation or soreness: mild discomfort at the site of placement. - Hiccups: transient diaphragmatic spasm. - Nausea: occasional upset stomach. - Increased salivation: excess oral fluid production. - Throat irritation: scratchy sensation. - Dyspepsia: indigestion or heartburn.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing. - Oral ulceration: painful sores in the mouth. - Cardiovascular events: palpitations, hypertension, or arrhythmia. - Severe dizziness or fainting. - Respiratory depression in susceptible individuals.

Use Nicotinell Tropical Fruit with caution and under professional guidance. - Cardiovascular assessment: evaluate patients with recent heart disease before initiating therapy. - Pregnancy and lactation: discuss potential risks with a healthcare provider; data are limited. - Pediatric use: not recommended for children or adolescents. - Concomitant nicotine sources: avoid using other nicotine products simultaneously. - Storage: Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine can interact with several medications, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Warfarin: nicotine may enhance anticoagulant effect, increasing bleeding risk. - Insulin: nicotine can affect glucose metabolism, potentially altering insulin requirements. - Beta‑blockers: nicotine‑induced tachycardia may be masked, complicating cardiovascular monitoring.

Moderate Interactions (Monitor Closely): - Theophylline: nicotine may increase plasma concentrations, raising toxicity risk. - CYP1A2 substrates (e.g., clozapine, olanzapine): nicotine induces metabolism, possibly reducing efficacy. - Selective serotonin reuptake inhibitors (SSRIs): monitor for heightened side‑effects such as nausea or insomnia.